Health Bulletin 21/October/2022

Here are the top health stories for the day:

MBBS Admission: Bombay HC orders medical re-examination of student with locomotor disability

While considering a plea by an MBBS aspirant with a locomotor disability, who had been deemed unfit for studying medical education, the Bombay High Court recently ordered his medical re-examination and directed the All India Institute of Physical Medicine and Rehabilitation (AIIPMR) to conduct the same.

The concerned student does not have five fingers to his right hand even though his left hand is normal and without any disability. However, he had been disqualified for MBBS admission by the Medical Board of National Eligibility-cum-Entrance Test (NEET).

His disability is calculated at 60% by Grant Government Medical College and Sir J.J. Group of Hospitals, which is the MCI Medical Board comprising of three senior Professors from the Departments of Orthopedic, Medicine, and Neurology. They have issued a certificate of disability for NEET admission dated 04.10.2022 declaring the present petitioner Ajinkya Ankush Budle not eligible to pursue the medical course as per the NMC norms.

For more details, check out the link given below:

MBBS Admission: Bombay HC orders medical re-examination of student with locomotor disability

Dengue patient tranfused with fruit juice instead of platelets dies, hospital sealed

In a bizarre incident, a private hospital in Prayagraj was sealed on Thursday after it was reported that they allegedly transferred sweet lime juice instead of plasma to a dengue patient who later passed away. The Uttar Pradesh Deputy Chief Minister Brajesh Pathak has ordered a probe into the incident.

A video allegedly exposing the incident from UP has gone viral on social media. It was shared on social media by a local journalist.

For more details, check out the link given below:

UP: Fruit Juice Infused Instead Of Plasma, Hospital Sealed After Dengue Patient Dies

Dr. Reddy's gets CDSCO panel conditional nod to manufacture, market Nimesulide Granules

Stressing that the drug product should only be made available with a prescription from a Registered Medical Practitioner, the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has granted approval to pharmaceutical major Dr. Reddy's Laboratories to manufacture and market Nimesulide Granules for Oral Suspension 100mg for "Short-term treatment of inflammatory conditions including joint disorders such as rheumatoid arthritis, post-operative painful conditions and fever".

The approval is subjected to condition that the drug product should be available only under prescription of a Registered Medical Practitioner. Furthermore, the expert panel stated that the prescription should contain clearly displayed Medical Council Registration No. of the Physician.

For more details, check out the link given below:

Dr. Reddy's Gets CDSCO Panel Conditional Nod To Manufacture, Market Nimesulide Granules

Scientists developing new diagnostic tool that can deliver health test results in two minutes

Scientists at Swansea University developing a platform that would use Artificial Intelligence to speed up the process of detecting biomarkers in biofluids have shown that the concept could work. It would mean faster test results for health conditions such as cardiovascular disorders, joint quality, and Alzheimer's.

This new diagnostic tool could revolutionise the healthcare sector due to the application of a form of artificial intelligence (AI) – machine learning (ML). The implementation of ML has meant it is possible, for the first time, for results to be delivered within minutes.

Biofluids such as synovial fluid, blood plasma, and saliva contain proteins that are an important biomarker for the diagnosis of several health conditions. The specially designed platform has been programmed to detect the concentration of these proteins to assist in diagnosis and monitoring disease progression.

Reference:

Francesco Del Giudice and Claire Barnes

Analytical Chemistry 2022 94 (8), 3617-3628

DOI: 10.1021/acs.analchem.1c05208